{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-071814","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2026-06-09T20:01:28+00:00","discovered_at":"2026-06-09T20:02:00.579942+00:00","generated_at":"2026-06-09T20:02:44.697112+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"German antitrust regulator clears Esperion acquisition by ArchiMed","bullets":["Bundeskartellamt cleared the merger effective June 2, 2026, as notified June 8.","Completion still requires HSR waiting period expiration and stockholder approval.","Special stockholder meeting to vote on merger scheduled for July 8, 2026, at 8:00 a.m. ET.","Merger announced May 1, 2026; Esperion to become wholly owned by ArchiMed affiliate."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-071814","json":"https://secwatch.observer/filing/0001104659-26-071814.json","markdown":"https://secwatch.observer/filing/0001104659-26-071814.md","text":"https://secwatch.observer/filing/0001104659-26-071814.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000110465926071814/0001104659-26-071814-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000110465926071814/tm2617356d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T20:02:44.697112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}